• Live-Dead Cell Staining Kit: Precision Assays for Viability

  2026-07-09

  The Live-Dead Cell Staining Kit enables robust, dual-fluorescence viability assessment in complex models, outperforming single-dye and non-fluorescent exclusion methods. Applied to cutting-edge workflows—like high-density 3D tumor bioprinting—this kit streamlines quantification and troubleshooting in both microscopy and flow cytometry.

• SC 79 Akt Activator: Optimizing Neuroprotection and Cell Sur

  2026-07-09

  SC 79, a cytosol-specific Akt activator from APExBIO, enables precise modulation of cell survival pathways for neuroprotection and metabolic stress models. This article delivers actionable workflows, troubleshooting strategies, and context-rich applications for researchers seeking robust, reproducible Akt activation.

• EMD638683: SGK1 Inhibitor Protocols for Vascular and Cancer

  2026-07-08

  EMD638683, a selective SGK1 inhibitor from APExBIO, unlocks precise control over endothelial and tumor cell pathways implicated in hypertension and cancer. This guide delivers actionable workflow enhancements, troubleshooting strategies, and the latest insights from both primary studies and expert resources to maximize research outcomes.

• DNase I (RNase-free): Elevating DNA Removal for RNA Extracti

  2026-07-08

  DNase I (RNase-free) redefines nucleic acid purity by enabling efficient, RNA-safe DNA removal—critical for advanced RNA extraction and sensitive RT-PCR workflows. Drawing on leading-edge tumor organoid research and comparative protocol perspectives, we outline how APExBIO’s enzyme empowers reliability and reproducibility in demanding molecular applications.

• Leveraging 2'3'-cGAMP to Surpass Tumor Immune Evasion

  2026-07-07

  This article delivers a mechanistic and strategic analysis of 2'3'-cGAMP (sodium salt) as an advanced tool for translational researchers. It synthesizes recent mechanistic breakthroughs—including tumor exosomal ENPP1’s role in cGAMP hydrolysis and STING pathway suppression—with best practices for experimental design. The discussion contextualizes APExBIO’s 2'3'-cGAMP (sodium salt) within the competitive landscape, guiding researchers seeking to unravel or therapeutically harness the cGAS-STING axis, and closes by outlining translational implications for immunotherapy.

• Applied Use-Cases for EZ Cap™ Firefly Luciferase mRNA in mRN

  2026-07-07

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure empowers translational researchers with robust, reproducible bioluminescent reporting—ideal for mRNA delivery, translation efficiency assays, and in vivo imaging. Its advanced capping and poly(A) tail engineering set a new benchmark for experimental sensitivity and signal stability.

• Brain-to-Spinal Circuits Modulate Mechanical Allodynia Later

  2026-07-06

  Huo et al. (2023) identify a contralateral brain-to-spinal circuit that determines both the side-specificity and persistence of mechanical allodynia in mice. Their work reveals distinct neuronal pathways that can prevent bilateral pain hypersensitivity after nerve injury, with implications for future pain research and animal model design.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance via PI3

  2026-07-06

  This study reveals how RCN2 promotes metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) by facilitating UBR5-mediated degradation of PPP2CA, leading to activation of the PI3K-Akt signaling pathway. These findings identify the RCN2-PPP2CA-PI3K-Akt axis as a promising molecular target for overcoming treatment resistance in ESCC.

• 6-Thioguanine Suppresses EV71 by Inhibiting BIRC3-Mediated A

  2026-07-05

  You et al. reveal that 6-thioguanine (6-TG) potently inhibits enterovirus 71 (EV71) replication in vitro by downregulating BIRC3, thereby reducing virus-induced autophagy. These findings identify a novel antiviral mechanism and support further investigation of autophagy modulation in virology.

• JHU-083: Unlocking Glutaminase Pathways in Neuroimmunology

  2026-07-04

  Explore how JHU-083, a 6-diazo-5-oxo-L-norleucine precursor, is reshaping experimental cerebral malaria and neurological disease models by targeting glutaminase in cerebral immune cells. This article unveils unique mechanistic and translational insights for glutaminase pathway research.

• GSTA1 Drives Glutathione Depletion in α-Amanitin Liver Toxic

  2026-07-03

  This study uncovers a paradoxical role for GSTA1 in α-amanitin-induced hepatotoxicity: instead of protecting the liver, upregulated GSTA1 accelerates glutathione depletion and exacerbates oxidative stress. These findings redefine GSTA1 as a potential therapeutic target and biomarker in acute toxin-mediated liver injury.

• Dual-Fluorescent Precision: Advancing Cell Viability in Tran

  2026-07-03

  This thought-leadership article unpacks the mechanistic power and strategic utility of Calcein-AM Propidium Iodide staining via the Live-Dead Cell Staining Kit (K2081) for translational researchers. Framed by advances in diabetic wound biomaterials and supported by scenario-driven workflow insights, it provides actionable guidance for experimental design, protocol optimization, and clinical relevance in cell viability assays.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-07-02

  The referenced study introduces a streamlined 13-step synthesis for deuterium-labeled degarelix acetate, enabling robust internal standards for pharmacokinetic and metabolic studies of this third-generation GnRH antagonist. The work supports advanced clinical research by improving the availability of labeled compounds essential for precise metabolic tracing.

• Structural Basis for MK 0893 Allosteric Inhibition of GCGR

  2026-07-02

  Jazayeri et al. provide the first high-resolution structure of the human glucagon receptor (GCGR) bound to the antagonist MK 0893, revealing a novel allosteric site between TM6 and TM7 that restricts receptor activation. This structural insight advances understanding of glucagon receptor antagonism and informs rational drug design for type 2 diabetes research.

• Applied Workflows with Dantrolene Sodium Salt: A Ryanodine R

  2026-07-01

  Dantrolene sodium salt, a nanomolar-potency ryanodine receptor antagonist, unlocks highly controlled calcium signaling modulation and repair pathway choice in advanced disease models and genome editing. This guide translates recent high-throughput findings into precise experimental workflows, protocol optimizations, and troubleshooting strategies for calcium-driven assays.

16751 records 1/1117 page Next 12345 下5页 Last page